Sign In
Buy XOMA
$41.70
+0.0100 (+0.0240%)
At Close: Jun 03, 2026
XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript
04:12pm, Wednesday, 18'th Mar 2026
XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
06:00am, Wednesday, 18'th Mar 2026
Portfolio receipts : • Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year 2025 • Total receipts increased 9% with royalties
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
06:30am, Thursday, 12'th Mar 2026
EMERYVILLE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty announced today it will report fourth quarter and full year 2025 financial results o
XOMA Royalty Corporation (NASDAQ:XOMA) Short Interest Update
01:03am, Tuesday, 03'rd Mar 2026
XOMA Royalty Corporation (NASDAQ: XOMA - Get Free Report) was the target of a significant growth in short interest in February. As of February 13th, there was short interest totaling 1,356,199 shares,
XOMA Royalty: Preferreds Still Offer Compelling Income Despite Call Risk
08:45pm, Tuesday, 10'th Feb 2026
XOMAO is XOMA Royalty Corporation's 8.375% cumulative preferred. I believe the core thesis centers on their dividend durability at this point. In my view, this means that as long as XOMA keeps a healt
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
09:53am, Monday, 09'th Feb 2026
EMERYVILLE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role i
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
10:00am, Thursday, 22'nd Jan 2026
NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ: XOMA). Such investors are advised t
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
04:47pm, Tuesday, 20'th Jan 2026
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation (“Xoma” or the “Company”) (NASDAQ: XOMA). Such investors ar
Nutra Pharma (OTCMKTS:NPHC) versus XOMA Royalty (NASDAQ:XOMA) Head-To-Head Review
03:31am, Sunday, 18'th Jan 2026
XOMA Royalty (NASDAQ: XOMA - Get Free Report) and Nutra Pharma (OTCMKTS:NPHC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesse
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
10:00am, Thursday, 15'th Jan 2026
NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ: XOMA). Such investors are advised t
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
04:34pm, Tuesday, 13'th Jan 2026
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation (“Xoma” or the “Company”) (NASDAQ: XOMA). Such investors ar
XOMA Royalty Announces CFO Transition
07:30am, Monday, 12'th Jan 2026
EMERYVILLE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) announced today its Chief Financial Officer, Thomas Burns, will be stepping down from
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
10:00am, Thursday, 08'th Jan 2026
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ: XOMA). Such investors are advised to
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
10:00am, Thursday, 01'st Jan 2026
NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ: XOMA). Such investors are advised to
XOMA Royalty Corporation (NASDAQ:XOMA) Short Interest Up 31.7% in December
02:13am, Tuesday, 30'th Dec 2025
XOMA Royalty Corporation (NASDAQ: XOMA - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling
